With FDA rejection to treat hives disorder, Sanofi and Regeneron's Dupixent suffers rare setback

23rd October 2023 Uncategorised 0

With FDA rejection to treat hives disorder, Sanofi and Regeneron’s Dupixent suffers rare setback
kdunleavy
Mon, 10/23/2023 – 10:19

More: With FDA rejection to treat hives disorder, Sanofi and Regeneron's Dupixent suffers rare setback
Source: fierce